speb/financial-data huggingface dataset:
CPAY balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 2769974000.00
CPAY balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 3266126000.00
CPAY balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 3266126000.00
CPAY balance_sheet (annual, 2024-12-31) — Current Liabilities: 8707881000.00
CPAY cash_flow (annual, 2024-12-31) — Deferred Income Tax: -64718000.00
CPAY cash_flow (annual, 2024-12-31) — Deferred Tax: -64718000.00
CPAY cash_flow (annual, 2024-12-31) — Depreciation: 120106000.00
CPAY cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 351088000.00
CPAY income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 351088000.00
CPAY cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 351088000.00
CPAY income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 351088000.00
CPAY income_statement (annual, 2024-12-31) — Diluted Average Shares: 71848000.00
CPAY income_statement (annual, 2024-12-31) — Diluted EPS: 13.97
CPAY income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 1003746000.00
CPAY income_statement (annual, 2024-12-31) — EBIT: 1768156000.00
CPAY income_statement (annual, 2024-12-31) — EBITDA: 2119244000.00
CPAY cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -223267000.00
CPAY cash_flow (annual, 2024-12-31) — End Cash Position: 4456345000.00
CPAY cash_flow (annual, 2024-12-31) — Financing Cash Flow: 404989000.00
CPAY cash_flow (annual, 2024-12-31) — Free Cash Flow: 1765389000.00
CPAY cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: -121310000.00
CPAY cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of Business: -121310000.00
CPAY income_statement (annual, 2024-12-31) — Gain On Sale Of Business: 121310000.00
CPAY income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -239000.00
CPAY income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 27000.00
CPAY balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -1713996000.00
CPAY income_statement (annual, 2024-12-31) — General And Administrative Expense: 616874000.00
CPAY balance_sheet (annual, 2024-12-31) — Goodwill: 5984667000.00
CPAY balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 8395109000.00
CPAY balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 2224257000.00
CPAY balance_sheet (annual, 2024-12-31) — Gross PPE: 954008000.00
CPAY balance_sheet (quarterly, 2024-12-31) — Gross PPE: 954008000.00
CPAY income_statement (annual, 2024-12-31) — Gross Profit: 3105504000.00
CPAY income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 90000000.00
CPAY cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 374039000.00
CPAY income_statement (annual, 2024-12-31) — Interest Expense: 383043000.00
CPAY income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 383043000.00
CPAY cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 496098000.00
CPAY balance_sheet (annual, 2024-12-31) — Invested Capital: 11118422000.00
CPAY cash_flow (annual, 2024-12-31) — Investing Cash Flow: -807477000.00
CPAY balance_sheet (annual, 2024-12-31) — Investments And Advances: 60088000.00
CPAY cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 428224000.00
CPAY cash_flow (annual, 2024-12-31) — Issuance Of Debt: 10830000000.00
CPAY balance_sheet (annual, 2024-12-31) — Line Of Credit: 1323000000.00
CPAY balance_sheet (annual, 2024-12-31) — Long Term Debt: 5226106000.00
CPAY balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 5226106000.00
CPAY cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 10814000000.00
CPAY cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -9558763000.00
CPAY balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 859946000.00
CPAY balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 859946000.00
CPAY balance_sheet (annual, 2024-12-31) — Minority Interest: 23647000.00
CPAY income_statement (annual, 2024-12-31) — Minority Interests: 14000.00
CPAY cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -636418000.00
CPAY cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -859774000.00
CPAY balance_sheet (annual, 2024-12-31) — Net Debt: 6442438000.00
CPAY income_statement (annual, 2024-12-31) — Net Income: 1003746000.00
CPAY income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 1003746000.00
CPAY income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 1003732000.00
CPAY income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 1003746000.00
CPAY income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 1003746000.00
CPAY cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 1003732000.00
CPAY income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 1003732000.00
CPAY income_statement (annual, 2024-12-31) — Net Interest Income: -383043000.00
CPAY cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 1271237000.00
CPAY cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 1255237000.00
CPAY income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -383043000.00
CPAY cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -6474000.00
CPAY cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 4117000.00
CPAY cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: 5570000.00
CPAY balance_sheet (annual, 2024-12-31) — Net PPE: 377705000.00
CPAY cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -175176000.00
CPAY cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 16000000.00
CPAY cash_flow (quarterly, 2024-12-31) — Net Short Term Debt Issuance: -147713000.00
CPAY balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -5272767000.00
CPAY balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 439176000.00
CPAY balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 439176000.00
CPAY income_statement (annual, 2024-12-31) — Normalized EBITDA: 2092974000.00
CPAY income_statement (annual, 2024-12-31) — Normalized Income: 984700250.00
CPAY cash_flow (annual, 2024-12-31) — Operating Cash Flow: 1940565000.00
CPAY cash_flow (annual, 2024-12-31) — Operating Gains Losses: -116270000.00
CPAY income_statement (annual, 2024-12-31) — Operating Income: 1755847000.00
CPAY income_statement (annual, 2024-12-31) — Operating Revenue: 3974589000.00
CPAY balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 70170016.00
CPAY balance_sheet (annual, 2024-12-31) — Other Current Assets: 806024000.00
CPAY balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 1446974000.00
CPAY balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 656417000.00
CPAY balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -1713996000.00
CPAY income_statement (annual, 2024-12-31) — Other Gand A: 616874000.00
CPAY income_statement (annual, 2024-12-31) — Other Income Expense: 12309000.00
CPAY balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 2410442000.00
CPAY cash_flow (annual, 2024-12-31) — Other Non Cash Items: 9022000.00
CPAY balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 448260000.00
CPAY balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 437879000.00
CPAY income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -13961000.00
CPAY income_statement (annual, 2024-12-31) — Other Operating Expenses: 789000.00
CPAY balance_sheet (annual, 2024-12-31) — Other Properties: 53820000.00
CPAY balance_sheet (quarterly, 2024-12-31) — Other Properties: 53820000.00
CPAY income_statement (annual, 2024-12-31) — Other Special Charges: 5040000.00
CPAY income_statement (quarterly, 2024-12-31) — Other Special Charges: 0.00
CPAY balance_sheet (annual, 2024-12-31) — Payables: 1699740000.00
CPAY balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 2015364000.00
CPAY income_statement (annual, 2024-12-31) — Pretax Income: 1385113000.00
CPAY balance_sheet (annual, 2024-12-31) — Properties: 0.00
CPAY balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
CPAY cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 103133000.00
CPAY cash_flow (annual, 2024-12-31) — Purchase Of Business: -821924000.00
CPAY cash_flow (annual, 2024-12-31) — Purchase Of PPE: -175176000.00
CPAY balance_sheet (annual, 2024-12-31) — Receivables: 2090500000.00
CPAY income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 869085000.00
CPAY income_statement (annual, 2024-12-31) — Reconciled Depreciation: 351088000.00
CPAY cash_flow (annual, 2024-12-31) — Repayment Of Debt: -9558763000.00
CPAY cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -1287998000.00
CPAY balance_sheet (annual, 2024-12-31) — Restricted Cash: 4225703000.00
CPAY balance_sheet (annual, 2024-12-31) — Retained Earnings: 9196405000.00
CPAY cash_flow (annual, 2024-12-31) — Sale Of Business: 185506000.00
CPAY cash_flow (quarterly, 2024-12-31) — Sale Of Business: 185506000.00
CPAY income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 380906000.00
CPAY income_statement (annual, 2024-12-31) — Selling General And Administration: 997780000.00
CPAY balance_sheet (annual, 2024-12-31) — Share Issued: 131425669.00
CPAY cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 16000000.00
CPAY income_statement (annual, 2024-12-31) — Special Income Charges: 26270000.00
CPAY cash_flow (annual, 2024-12-31) — Stock Based Compensation: 116724000.00
CPAY balance_sheet (annual, 2024-12-31) — Stockholders Equity: 3122342000.00
CPAY balance_sheet (annual, 2024-12-31) — Tangible Book Value: -5272767000.00
CPAY income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 7224250.00
CPAY income_statement (annual, 2024-12-31) — Tax Provision: 381381000.00
CPAY income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.28
CPAY balance_sheet (annual, 2024-12-31) — Total Assets: 17957031000.00
CPAY balance_sheet (annual, 2024-12-31) — Total Capitalization: 8348448000.00
CPAY balance_sheet (annual, 2024-12-31) — Total Debt: 7996080000.00
CPAY balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 3145989000.00
CPAY income_statement (annual, 2024-12-31) — Total Expenses: 2218742000.00
CPAY balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 14811042000.00
CPAY balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 9281162000.00
CPAY balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 6103161000.00
CPAY income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 1787157000.00
CPAY balance_sheet (annual, 2024-12-31) — Total Tax Payable: 129314000.00
CPAY balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 129314000.00
CPAY income_statement (annual, 2024-12-31) — Total Unusual Items: 26270000.00
CPAY income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 26270000.00
CPAY balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 61255653.00
CPAY balance_sheet (annual, 2024-12-31) — Treasury Stock: 8171329000.00
CPAY balance_sheet (annual, 2024-12-31) — Working Capital: -32012000.00
CPAY income_statement (quarterly, 2025-03-31) — +Operating Expense: 356699000.00
CPAY income_statement (quarterly, 2025-03-31) — +Total Revenue: 1005667000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1811737000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 4015819000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 3850115000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -146244000.00
CPAY cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 63792000.00
CPAY cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 63792000.00
CPAY income_statement (quarterly, 2025-03-31) — Average Dilution Earnings: 0.00
CPAY income_statement (quarterly, 2025-03-31) — Basic Average Shares: 70316000.00
CPAY income_statement (quarterly, 2025-03-31) — Basic EPS: 3.46
CPAY cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 4456345000.00
CPAY cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -44771000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Capital Stock: 132000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1554835000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1554835000.00
CPAY cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 142297000.00
CPAY cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -183918000.00
CPAY cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -74151000.00
CPAY cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 126400000.00
CPAY cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 991000.00
CPAY cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 10442000.00
CPAY cash_flow (quarterly, 2025-03-31) — Change In Payable: 126400000.00
CPAY cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 126400000.00
CPAY cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -27266000.00
CPAY cash_flow (quarterly, 2025-03-31) — Change In Receivables: -565649000.00
CPAY cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -455082000.00
CPAY cash_flow (quarterly, 2025-03-31) — Changes In Cash: -115772000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Common Stock: 132000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 3453836000.00
CPAY cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 32079000.00
CPAY cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -58718000.00
CPAY income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 221844000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 412359000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Current Assets: 9077561000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Current Debt: 2254918000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 2254918000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 3228068000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 3228068000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 8236670000.00
CPAY cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -7983000.00
CPAY cash_flow (quarterly, 2025-03-31) — Deferred Tax: -7983000.00
CPAY cash_flow (quarterly, 2025-03-31) — Depreciation: 28396000.00
CPAY cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 92188000.00
CPAY income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 92188000.00
CPAY cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 92188000.00
CPAY income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 92188000.00
CPAY income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 71558000.00
CPAY income_statement (quarterly, 2025-03-31) — Diluted EPS: 3.40
CPAY income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 243233000.00
CPAY income_statement (quarterly, 2025-03-31) — EBIT: 421433000.00
CPAY income_statement (quarterly, 2025-03-31) — EBITDA: 513621000.00
CPAY cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 42850000.00
CPAY cash_flow (quarterly, 2025-03-31) — End Cash Position: 4383423000.00
CPAY cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 142297000.00
CPAY cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -118922000.00
CPAY cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of Business: 0.00
CPAY income_statement (quarterly, 2025-03-31) — Gain On Sale Of Business: 0.00
CPAY balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -1606002000.00
CPAY income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 156959000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Goodwill: 6191687000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 8599243000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 4162063000.00
CPAY income_statement (quarterly, 2025-03-31) — Gross Profit: 783823000.00
CPAY cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 114745000.00
CPAY income_statement (quarterly, 2025-03-31) — Interest Expense: 93922000.00
CPAY income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 93922000.00
CPAY cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 119022000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Invested Capital: 11625239000.00
CPAY cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -183918000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 62674000.00
CPAY cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 32079000.00
CPAY cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 3350000000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Line Of Credit: 1469000000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 5916485000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 5916485000.00
CPAY cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 3204000000.00
CPAY cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -3169285000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Minority Interest: 40246000.00
CPAY income_statement (quarterly, 2025-03-31) — Minority Interests: -642000.00
CPAY cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -153719000.00
CPAY cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -26639000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Net Debt: 6616568000.00
CPAY income_statement (quarterly, 2025-03-31) — Net Income: 243233000.00
CPAY income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 243233000.00
CPAY income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 243875000.00
CPAY income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 243233000.00
CPAY income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 243233000.00
CPAY cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 243875000.00
CPAY income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 243875000.00
CPAY income_statement (quarterly, 2025-03-31) — Net Interest Income: -93922000.00
CPAY cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 180715000.00
CPAY cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 34715000.00
CPAY income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -93922000.00
CPAY cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -11779000.00
CPAY cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 14572000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Net PPE: 401523000.00
CPAY cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -44771000.00
CPAY cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: 146000000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -5145407000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 431022000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 431022000.00
CPAY income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 515217000.00
CPAY income_statement (quarterly, 2025-03-31) — Normalized Income: 244422020.00
CPAY cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -74151000.00
CPAY cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 1596000.00
CPAY income_statement (quarterly, 2025-03-31) — Operating Income: 427124000.00
CPAY income_statement (quarterly, 2025-03-31) — Operating Revenue: 1005667000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 70471590.00
CPAY balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 678319000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 785918000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 529588000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -1606002000.00
CPAY income_statement (quarterly, 2025-03-31) — Other Gand A: 156959000.00
CPAY income_statement (quarterly, 2025-03-31) — Other Income Expense: -5691000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 2407556000.00
CPAY cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 2228000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 406779000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 469521000.00
CPAY income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -4095000.00
CPAY income_statement (quarterly, 2025-03-31) — Other Operating Expenses: -5000.00
CPAY income_statement (quarterly, 2025-03-31) — Other Special Charges: 1596000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Payables: 1811737000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 2224096000.00
CPAY income_statement (quarterly, 2025-03-31) — Pretax Income: 327511000.00
CPAY cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 30661000.00
CPAY cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -153719000.00
CPAY cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -44771000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Receivables: 4015819000.00
CPAY income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 221844000.00
CPAY income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 92188000.00
CPAY cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -3169285000.00
CPAY cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -58718000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 2828588000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 9439638000.00
CPAY cash_flow (quarterly, 2025-03-31) — Sale Of Business: 0.00
CPAY income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 107557000.00
CPAY income_statement (quarterly, 2025-03-31) — Selling General And Administration: 264516000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Share Issued: 131884477.00
CPAY cash_flow (quarterly, 2025-03-31) — Short Term Debt Issuance: 146000000.00
CPAY income_statement (quarterly, 2025-03-31) — Special Income Charges: -1596000.00
CPAY cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 18366000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 3453836000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -5145407000.00
CPAY income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -406980.00
CPAY income_statement (quarterly, 2025-03-31) — Tax Provision: 83636000.00
CPAY income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.26
CPAY balance_sheet (quarterly, 2025-03-31) — Total Assets: 18547780000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 9370321000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Total Debt: 8171403000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 3494082000.00
CPAY income_statement (quarterly, 2025-03-31) — Total Expenses: 578543000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 15053698000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 9470219000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 6817028000.00
CPAY income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 427124000.00
CPAY income_statement (quarterly, 2025-03-31) — Total Unusual Items: -1596000.00
CPAY income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -1596000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 61412887.00
CPAY balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 8230047000.00
CPAY balance_sheet (quarterly, 2025-03-31) — Working Capital: 840891000.00
CPAY income_statement (quarterly, 2025-06-30) — +Operating Expense: 384123000.00
CPAY income_statement (quarterly, 2025-06-30) — +Total Revenue: 1102030000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1974528000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 4240292000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 3902867000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -155847000.00
CPAY cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 61569000.00
CPAY cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 61569000.00
CPAY income_statement (quarterly, 2025-06-30) — Basic Average Shares: 70546000.00
CPAY income_statement (quarterly, 2025-06-30) — Basic EPS: 4.03
CPAY cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 4383423000.00
CPAY cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -52636000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Capital Stock: 132000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 2192849000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 2192849000.00
CPAY cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -63942000.00
CPAY cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -38722000.00
CPAY cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 1140247000.00
CPAY cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 19912000.00
CPAY cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -54217000.00
CPAY cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 945000000.00
CPAY cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -7931000.00
CPAY cash_flow (quarterly, 2025-06-30) — Change In Receivables: -174712000.00
CPAY cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 728052000.00
CPAY cash_flow (quarterly, 2025-06-30) — Changes In Cash: 1037583000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Common Stock: 132000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 3928573000.00
CPAY cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 23883000.00
CPAY cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -32159000.00
CPAY income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 238517000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 450207000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Current Assets: 10759243000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Current Debt: 2248617000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 2248617000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 4143205000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 4143205000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 9639769000.00
CPAY cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -17516000.00
CPAY cash_flow (quarterly, 2025-06-30) — Deferred Tax: -17516000.00
CPAY cash_flow (quarterly, 2025-06-30) — Depreciation: 29781000.00
CPAY cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 91350000.00
CPAY income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 91350000.00
CPAY cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 91350000.00
CPAY income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 91350000.00
CPAY income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 71429000.00
CPAY income_statement (quarterly, 2025-06-30) — Diluted EPS: 3.98
CPAY income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 284168000.00
CPAY income_statement (quarterly, 2025-06-30) — EBIT: 489962000.00
CPAY income_statement (quarterly, 2025-06-30) — EBITDA: 581312000.00
CPAY cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 110352000.00
CPAY cash_flow (quarterly, 2025-06-30) — End Cash Position: 5531358000.00
CPAY cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -63942000.00
CPAY cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 1087611000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -1436386000.00
CPAY income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 176994000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Goodwill: 6334018000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 8706323000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 4396139000.00
CPAY income_statement (quarterly, 2025-06-30) — Gross Profit: 863513000.00
CPAY cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 147242000.00
CPAY income_statement (quarterly, 2025-06-30) — Interest Expense: 96872000.00
CPAY income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 96872000.00
CPAY cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 119774000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Invested Capital: 12046273000.00
CPAY cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -38722000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 58319000.00
CPAY cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 23883000.00
CPAY cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 2230000000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Line Of Credit: 1639000000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 5869083000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 5869083000.00
CPAY cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 2376000000.00
CPAY cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -2286285000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Minority Interest: 38606000.00
CPAY income_statement (quarterly, 2025-06-30) — Minority Interests: 90000.00
CPAY cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -929000.00
CPAY cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -8276000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Net Debt: 5924851000.00
CPAY income_statement (quarterly, 2025-06-30) — Net Income: 284168000.00
CPAY income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 284168000.00
CPAY income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 284078000.00
CPAY income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 284168000.00
CPAY income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 284168000.00
CPAY cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 284078000.00
CPAY income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 284078000.00
CPAY income_statement (quarterly, 2025-06-30) — Net Interest Income: -96872000.00
CPAY cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -56285000.00
CPAY cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 89715000.00
CPAY income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -96872000.00
CPAY cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 619000.00
CPAY cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 0.00
CPAY balance_sheet (quarterly, 2025-06-30) — Net PPE: 434319000.00
CPAY cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -52636000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -4777750000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 379240000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 379240000.00
CPAY income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 581312000.00
CPAY income_statement (quarterly, 2025-06-30) — Normalized Income: 284168000.00
CPAY cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 1140247000.00
CPAY cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 0.00
CPAY income_statement (quarterly, 2025-06-30) — Operating Income: 479390000.00
CPAY income_statement (quarterly, 2025-06-30) — Operating Revenue: 1102030000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 70610228.00
CPAY balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 987593000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 609617000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 823212000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -1436386000.00
CPAY income_statement (quarterly, 2025-06-30) — Other Gand A: 176994000.00
CPAY income_statement (quarterly, 2025-06-30) — Other Income Expense: 10572000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 2372305000.00
CPAY cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -6086000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 477022000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 579955000.00
CPAY income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 10572000.00
CPAY income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 2000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Payables: 1974528000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 2424735000.00
CPAY income_statement (quarterly, 2025-06-30) — Pretax Income: 393090000.00
CPAY cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 31501000.00
CPAY cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -929000.00
CPAY cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -52636000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Receivables: 4240292000.00
CPAY income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 238517000.00
CPAY income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 91350000.00
CPAY cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -2286285000.00
CPAY cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -32159000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 3338509000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 9723806000.00
CPAY income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 115777000.00
CPAY income_statement (quarterly, 2025-06-30) — Selling General And Administration: 292771000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Share Issued: 132115444.00
CPAY income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
CPAY cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 28868000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 3928573000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -4777750000.00
CPAY income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CPAY income_statement (quarterly, 2025-06-30) — Tax Provision: 109012000.00
CPAY income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.28
CPAY balance_sheet (quarterly, 2025-06-30) — Total Assets: 20435226000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 9797656000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Total Debt: 8117700000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 3967179000.00
CPAY income_statement (quarterly, 2025-06-30) — Total Expenses: 622640000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 16468047000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 9675983000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 6828278000.00
CPAY income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 479390000.00
CPAY income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
CPAY income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
CPAY balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 61505216.00
CPAY balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 8261846000.00
CPAY balance_sheet (quarterly, 2025-06-30) — Working Capital: 1119474000.00
CPAY income_statement (quarterly, 2025-09-30) — +Operating Expense: 400599000.00
CPAY income_statement (quarterly, 2025-09-30) — +Total Revenue: 1172480000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1966464000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 4412279000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 3937515000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -166866000.00
CPAY cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 60396000.00
CPAY cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 60396000.00
CPAY income_statement (quarterly, 2025-09-30) — Basic Average Shares: 70318000.00
CPAY income_statement (quarterly, 2025-09-30) — Basic EPS: 3.95
CPAY cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 5531358000.00
CPAY cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -50908000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Capital Stock: 132000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 2005508000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 2005508000.00
CPAY cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -180640000.00
CPAY cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -60282000.00
CPAY cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -378933000.00
CPAY cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -9191000.00
CPAY cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -13720000.00
CPAY cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -580516000.00
CPAY cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -18680000.00
CPAY cash_flow (quarterly, 2025-09-30) — Change In Receivables: -192847000.00
CPAY cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -814954000.00
CPAY cash_flow (quarterly, 2025-09-30) — Changes In Cash: -619855000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Common Stock: 132000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 4075691000.00
CPAY cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 7056000.00
CPAY cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -191706000.00
CPAY income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 248761000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 533680000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Current Assets: 10108154000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Current Debt: 2301280000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 2301280000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 3501046000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 3501046000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 8912270000.00
CPAY cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -13004000.00
CPAY cash_flow (quarterly, 2025-09-30) — Deferred Tax: -13004000.00
CPAY cash_flow (quarterly, 2025-09-30) — Depreciation: 32767000.00
CPAY cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 93163000.00
CPAY income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 93163000.00
CPAY cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 93163000.00
CPAY income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 93163000.00
CPAY income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 71131000.00
CPAY income_statement (quarterly, 2025-09-30) — Diluted EPS: 3.91
CPAY income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 277941000.00
CPAY income_statement (quarterly, 2025-09-30) — EBIT: 521737000.00
CPAY income_statement (quarterly, 2025-09-30) — EBITDA: 614900000.00
CPAY cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 2890000.00
CPAY cash_flow (quarterly, 2025-09-30) — End Cash Position: 4914393000.00
CPAY cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -180640000.00
CPAY cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -429841000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -1410151000.00
CPAY income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 178611000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Goodwill: 6337077000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 8648072000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 4579145000.00
CPAY income_statement (quarterly, 2025-09-30) — Gross Profit: 923719000.00
CPAY cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 119416000.00
CPAY income_statement (quarterly, 2025-09-30) — Interest Expense: 100035000.00
CPAY income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 100035000.00
CPAY cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 118581000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Invested Capital: 12198643000.00
CPAY cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -60282000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 58679000.00
CPAY cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 7056000.00
CPAY cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 2037692000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Line Of Credit: 1755000000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 5821672000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 5821672000.00
CPAY cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 1605000000.00
CPAY cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -2033285000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Minority Interest: 43441000.00
CPAY income_statement (quarterly, 2025-09-30) — Minority Interests: -438000.00
CPAY cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
CPAY cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -184650000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Net Debt: 6117444000.00
CPAY income_statement (quarterly, 2025-09-30) — Net Income: 277941000.00
CPAY income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 277941000.00
CPAY income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 278379000.00
CPAY income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 277941000.00
CPAY income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 277941000.00
CPAY cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 278379000.00
CPAY income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 278379000.00
CPAY income_statement (quarterly, 2025-09-30) — Net Interest Income: -100035000.00
CPAY cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 0.00
CPAY cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 4407000.00
CPAY cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -428285000.00
CPAY income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -100035000.00
CPAY cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -397000.00
CPAY cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -9374000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Net PPE: 453101000.00
CPAY cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -50908000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -4572381000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 371959000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 371959000.00
CPAY income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 614900000.00
CPAY income_statement (quarterly, 2025-09-30) — Normalized Income: 277941000.00
CPAY cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -378933000.00
CPAY cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 0.00
CPAY income_statement (quarterly, 2025-09-30) — Operating Income: 523120000.00
CPAY income_statement (quarterly, 2025-09-30) — Operating Revenue: 1172480000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 70042461.00
CPAY balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 781482000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 546280000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 609800000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -1410151000.00
CPAY income_statement (quarterly, 2025-09-30) — Other Gand A: 178611000.00
CPAY income_statement (quarterly, 2025-09-30) — Other Income Expense: -1383000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 2310995000.00
CPAY cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 22212000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 476831000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 519804000.00
CPAY income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -1383000.00
CPAY income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 11197000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Payables: 1966464000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 2500144000.00
CPAY income_statement (quarterly, 2025-09-30) — Pretax Income: 421702000.00
CPAY cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 27679000.00
CPAY cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 0.00
CPAY cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -50908000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Receivables: 4412279000.00
CPAY income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 248761000.00
CPAY income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 93163000.00
CPAY cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -2033285000.00
CPAY cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -191706000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 2908885000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 10001747000.00
CPAY cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 0.00
CPAY income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 117628000.00
CPAY income_statement (quarterly, 2025-09-30) — Selling General And Administration: 296239000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Share Issued: 132159162.00
CPAY income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
CPAY cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 27592000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 4075691000.00
CPAY balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -4572381000.00
CPAY income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00